-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Armata Pharmaceuticals, Raises Price Target to $15

Benzinga·02/23/2026 15:59:38
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:ARMP) with a Buy and raises the price target from $9 to $15.